Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Haemonetics (HAE) Non Operating Income (2016 - 2025)

Haemonetics has reported Non Operating Income over the past 17 years, most recently at -$7.4 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 18.56% year-over-year to -$7.4 million; the TTM value through Dec 2025 reached -$23.9 million, down 52.63%, while the annual FY2025 figure was -$9.7 million, 25.13% up from the prior year.
  • Non Operating Income for Q4 2025 was -$7.4 million at Haemonetics, down from -$7.2 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $7.0 million in Q2 2024 and troughed at -$9.1 million in Q4 2024.
  • A 5-year average of -$4.2 million and a median of -$4.5 million in 2021 define the central range for Non Operating Income.
  • On a YoY basis, Non Operating Income climbed as much as 436.25% in 2024 and fell as far as 367.52% in 2024.
  • Year by year, Non Operating Income stood at -$4.6 million in 2021, then surged by 77.01% to -$1.1 million in 2022, then plummeted by 84.74% to -$1.9 million in 2023, then crashed by 367.52% to -$9.1 million in 2024, then grew by 18.56% to -$7.4 million in 2025.
  • Business Quant data shows Non Operating Income for HAE at -$7.4 million in Q4 2025, -$7.2 million in Q3 2025, and -$8.7 million in Q2 2025.